and swallowing. Her medications were therefore increased, and she was stabilised on a higher dosage of anticholinesterase therapy (pyridostigmine 120 mg sixth hourly). She remained on this regimen throughout the remainder of her pregnancy.
At 32 weeks' gestation she was admitted to hospital in premature labour, and was commenced on oral salbutamol. She remained in hospital on salbutamol therapy for the duration of her pregnancy. There was a continued improvement in general muscle strength during this time and bulbar weakness, although marked at the time of her admission, was minimal by the end of the pregnancy. The salbutamol was ceased at 39 weeks' gestation, and within 24 hours the patient was in labour. She was changed from oral to parenteral medications, but because of varying reports in the literature about the exact ratios involved when changing from oral to parenteral anticholinesterase therapy, the initial intramuscular doses of pyridostigmine administered were very conservative. Intravenous hydrocortisone 100 mg eighth hourly replaced the oral prednisone. Obstetrical review after several hours revealed an unfavourable cervix, and it was felt that a protracted labour could be anticipated. To avoid a prolonged and exhausting labour it was decided to perform a caesarean section.
An epidural block was performed at L2-3 interspace, using 2070 lignocaine 16 ml with adrenaline 1 :200,000 mixed with 5 ml normal saline and a catheter inserted. The resulting level of analgesia extended to T5 which provided good conditions for surgery. Motor loss was not extensive and no respiratory difficulties were encountered. Caesarean Anaesthesia and Intensive Care, Vol. I J, No. 3, August, 1983 section was uneventful, and the patient was delivered of a live female infant weighing 3760 grams. The baby required no special resuscitation, nor did it mani fest any signs of weakness at birth. Postoperative analgesia was maintained with top-ups of 8 ml doses of 0.25070 bupivacaine which proved satisfactory initially, but later top-ups provided only unilateral analgesia. For the next two days analgesia was provided by a continuous intravenous infusion of papaveretum. The patient was maintained on intramuscular pyridostigmine after delivery starting with 4 mg every six hours. This proved inadequate, and an edrophonium test performed approximately fourteen hours after the caesarean section demonstrated the need for an increase in anticholinesterase therapy. Over the next twenty-four hours, the dose was increased to 4 mg intramuscularly every three hours, with continuance of intravenous hydrocortisone 100 mg eighth hourly. To avoid the need for large and frequent intramuscular injections, the intravenous route at the same dose of pyridostigmine was used subsequently. This provided satisfactory control and the patient resumed oral medications on the third postoperative day. The first three post partum days were marked by fluctuations in the patient's clinical status, with obvious deterioration following periods with little sleep or rest, or when the patient became particularly anxious about the baby's condition. Throughout this time, the patient provided several reliable guidelines to the adequacy of her medications. Her speech was one of the first things to deteriorate, with marked slurring and difficulty with enunciation of words. Because she was an intelligent young woman, well acquainted with her disease, she was extremely accurate in assessing both the adequacy of dosage and the need to increase the frequency in pyridostigmine injections. In addition to subjective measurements of muscle strength by both staff and the patient, hourly tidal volume and vital capacity measurements were monitored using a Wright's respirometer.
The patient's condition did deteriorate from her ante partum status in the first 1-2 weeks after delivery, and her anticholinesterase therapy was increased accordingly. For the first three days she was nursed in labour ward with a Anaesthesia and Intensive Care. Vol. 11, No. 3, August, 1983 "special" nurse in constant attendance. After this it was felt she had improved sufficiently to be cared for in the general ward.
The baby began to show signs of weakness, as evidenced by decreased spontaneous movements and peripheral tone, poor sucking, and absent gag reflex between 12-16 hours after birth. She responded to initial doses of 0.5 mg/kg intramuscular neostigmine every four hours. On day 3 this was changed to oral pyridostigmine which was continued for 10 days and then gradually decreased over the next three to four weeks before being discontinued.
DISCUSSION
Myasthenia gravis results from an autoimmune process, with anti-acetylcholinereceptor antibodies having now been identified by various means. 2 These 19G antibodies lead to an accelerated breakdown of acetylcholine receptors, as well as causing some degree of receptor blockade. 2 ,1 The resulting decrease in the number of available ACh receptors forms the basis of the clinical manifestations of the disease. It seems likely that some abnormality of T-cell function may be responsible for the development of this humoral autoimmune response. It is unclear to what extent the cellmediated immune system is also involved.
The mainstay of treatment involves the use of oral anticholinesterase agents, the dosage being tailored to provide optimal symptomatic relief. Thymectomy, particularly in patients under 50 years of age, or in the presence of a thymoma, results in improvement in 57-86070 of patients, with remission in 20-36%.4 Corticosteroids are used for their immunosuppressive actions, and improvement has been forthcoming in from 70-100% of patients,4 particularly when used as an adjuvant to anticholinesterase therapy and thymectomy. Immunosuppressive therapy, plasmapheresis, and thoracic duct drainage have also been used in resistant cases with some success. 4 Successful management of the myasthenic patient during confinement is dependent on team management, with physician, neurologist, obstetrician and anaesthetist all being involved.
The course of myasthenia gravis during pregnancy is unpredictable. While 55% of myasthenics have a gestational-related exacerbation, approximately one-third of myasthenic women will show an improvement during pregnancy. S Premature labour may occur more frequently in myasthenics. 6 This may be related to the action of increased circulating amounts of acetylcholine (resulting from anticholinesterase therapy) on uterine cholinergic receptors. Induced abortion does not appear to alter the course of the disease,s and there is no indication for therapeutic abortion on the basis of pre-existing myasthenia gravis alone.
Once labour is established the absorption of drugs administered orally is unpredictable so the patient should be changed to parenteral medications. If the patient has had episodes of premature labour and is maintained on uterinerelaxing medications it would seem best to complete the changeover to parenteral medications before ceasing these. In retrospect such a plan may have allowed a smoother course in the first 1-2 days post partum in this patient. There is some disagreement in the literature regarding dosage when changing to parenteral therapy. Equipotent doses are: neostigmine 0.5 mg intravenously, neostigmine 0.7-1.5 mg intramuscularly, neostigmine 15 mg orally, or pyridostigmine 60 mg orally. Most authorities recommend the use of intramuscular injections yet this is unnecessary and is extremely painful for the patient, particularly if large volumes and frequent injections are required. In the case described the use of intravenous bolus injections provided adequate control, with less fluctuation in clinical state than occurred with intramuscular injections.
During labour and in the immediate post partum period, close watch must be kept on the adeq uacy of anticholinesterase therapy. Continued observation for bulbar weakness, particularly difficulty in swallowing, ophthalmoplegia and tests of motor power provide useful information. In this patient speech was a very sensitive indicator showing early deterioration when anticholinesterase therapy was inadequate. Objective evaluation of the degree of respiratory muscle weakness can be made by hourly measurements of tidal volume and vital capacity using a Wright's respirometer.
Myasthenia gravis does not affect the course of labour and is not, of itself, an indication for caesarean section. 6 However, an excessively long and painful labour, which would be exhausting for the patient, is obviously undesirable. Many authorities recommend the use of outlet forceps to shorten the second stage and to minimise the exertion involved in pushing. s ,6 Most patients with myasthenia gravis deliver vaginally, and the use of segmental local analgesia has been recommended. s The use of small volumes of low-concentration local anaesthetic solutions to attain a segmental epidural block (TlI-12) with minimal motor blockade would appear to be the method of choice for providing analgesia during the first stage of labour, with progression to a caudal block for the second stage. It is said that myasthenics are particularly sensitive to the effects of hypnotics, sedatives and narcotics, I although whether this represents in fact a true increase in sensitivity or normal sensitivity in a patient with a decreased margin of safety with respect to respiratory function, is not clear. Any central nervous system depressants should be administered cautiously and in reduced dosage.
Caesarean section if indicated may be performed under general or regional anaesthesia. Endotracheal anaesthesia can ensure protection of the airway, especially where bulbar weakness is a problem, and adequate ventilation. If the patient is very weak, intubation may be able to be accomplished without the use of a muscle relaxant. The use of nondepolarising relaxants is probably unnecessary and furthermore may lead to the need for postoperative ventilation of the patient.
Because this patient had good muscle power at the time of operation, with no bulbar weakness, it was felt that there was no need for concern about the possibility of regurgitation and inhalation associated with bulbar weakness, and that epidural analgesia could be administered safely. To minimise the degree of motor blockade, a more dilute solution of local anaesthetic than normal was used. The level of sensory blockade provided satisfactory conditions for surgery, while motor blockade was not excessive in intensity, distribution or duration. The prOVISIon of adequate postoperative analgesia was considered an important factor in preventing or minimising Anaesthesia and Inlensive Care, Vol. 11, No. 3, August, 1983 any deterioration in the patient's condition in the early post partum period. Exacerbations of myasthenia gravis occur in one-third of patients within three weeks of delivery.
Transient neonatal myasthenia occurs in 21070 of babies born to myasthenic mothers, and is due to the transplacental passage of acetylcholine receptor antibodies. s Symptoms may not be present at birth, but appear within the first 48 hours of life. Rapid improvement in muscle weakness follows the use of anticholinesterases, and therapy can be reduced as the baby's strength improves over subsequent weeks. Anticholinesterase therapy is generally needed for about three weeks. 6 occasional rales at the bases. His ECG was normal and chest X-ray report stated "lung markings are increased in each lower zone and some infection could be present. The heart is difficult to assess due to rotation of the patient". Serum electrolytes were normal. The patient had been fasting and receiving intravenous fluids for two days.
After preoxygenation, anaesthesia was commenced with thiopentone 3 mg/kg, suxamethonium 1 mg/kg and fentanyl 1.5 J.lg/kg, employing Sellick's manoeuvre until after intubation with a 9.0 mm I.D. Magill cuffed endotracheal tube. Muscle relaxation was maintained with alcuronium 0.15 mg/kg and pancuronium 0.06 mg/kg (initial dosage) with a supplement of alcuronium 2.5 mg.
